logo
Plus   Neg
Share
Email

SoftBank To Record Gain On Loss Of Control Of Sprint - Quick Facts

SoftBank Group Corp. (SFTBY.PK,SFTBF.PK) said it expects to record a gain of approximately 750 billion yen relating to loss of control of Sprint, under net income from discontinued operations in its consolidated statement of income for three-month period ending June 30, 2020. This is due to Sprint ceasing to be a subsidiary of SBG upon completion of the merger with T Mobile US.

Separately, the Group announced additional corporate governance enhancements, including the election by shareholders of two new independent directors. Lip-Bu Tan, Founder and Chairman of Walden International Inc. and CEO of Cadence Design Systems,
and Yuko Kawamoto, Professor at Waseda Business School, were elected. Yoshimitsu Goto, Senior Vice President, CFO, CISO & CSusO at SBG, was also elected to the Board.

The Board has approved the formation of a new Nominating & Compensation Committee, which will be comprised of a majority of independent directors and no less than three Board Directors. The committee will be Chaired by independent director, Masami
Iijima, and Yutaka Matsuo and Masayoshi Son will also serve on the committee.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its second-quarter operating profit will rise about 22.73 percent from last year, due to increasing demand for server chips as countries around the world adopt work-from-home measures during the coronavirus pandemic. But, it projects sales will decrease 7.36 percent. Ford plans to bring back the Bronco as a dedicated off-road brand when it launches an all-new 4x4 SUV lineup on July 13. The automaker said it will introduce an all-new Bronco brand under the tagline, "Built Wild". The new lineup includes two-door and four-door models of the Bronco as well as the Bronco Sport compact SUV. J. M. Smucker Co. is recalling certain Natural Balance canned cat food, citing health concerns likely associated with increased levels of choline chloride, an animal growth promotant, the U.S. Food and Drug Administration said in a statement. The recall was initiated after receiving reports of adverse reactions.
Follow RTT